Skip to content
OpenCapital
Earnings
Screener
Portfolio
Pricing
Connect your AI
Get started
Toggle navigation menu
Stocks
Relmada Therapeutics, Inc.
Income Statement
Income Statement
Balance Sheet
Cash Flow
Segments
Relmada Therapeutics, Inc. Income Statement
Revenue, expenses, and profitability over time
Market Cap
$683.9M
No metrics found for this filter.
